| Tracy L Swalm, CNM | |
|
99 Tavern Rd, Martinsburg, WV 25401-2890 | |
| (304) 264-2066 | |
| Not Available |
| Full Name | Tracy L Swalm |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 99 Tavern Rd, Martinsburg, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174768121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 155 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tracy L Swalm, CNM Po Box 1146, Martinsburg, WV 25402-1146 Ph: () - | Tracy L Swalm, CNM 99 Tavern Rd, Martinsburg, WV 25401-2890 Ph: (304) 264-2066 |
News Archive
People in the late stages of cancer and other terminal illnesses are not only unharmed by discontinuing statins for cholesterol management, they may benefit, according to a study presented Friday by researchers at Duke Medicine representing a national research network.
Akonni Biosystems, a molecular diagnostics company focused on providing rapid and highly scalable solutions for infectious and genetic disease testing, today announced the launch of a TruTip kit for extraction of human genomic DNA from fresh or frozen whole blood.
This week, TCA Cellular Therapy's Medical Director Gabriel Lasala, M.D. presents advances in a proprietary combination adult stem cell treatment for acute myocardial infarction at the Society for Cardiovascular Angiography and Interventions (SCAI) scientific conference in San Diego.
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
› Verified 9 days ago
April Marshall, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 99 Tavern Rd, Martinsburg, WV 25401 Phone: 304-263-4999 Fax: 304-263-0984 | |
Carol L Decker, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 99 Tavern Rd, Martinsburg, WV 25401 Phone: 304-263-0984 | |
Mrs. Danielle Lynn Isbell, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 99 Tavern Rd, Martinsburg, WV 25401 Phone: 304-263-4999 Fax: 505-722-1765 | |
Sabrina Austin, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 99 Tavern Rd, Martinsburg, WV 25401 Phone: 304-263-4999 Fax: 304-263-0984 | |
Glenda Leanne Kay, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 99 Tavern Rd, Martinsburg, WV 25401 Phone: 304-263-4999 Fax: 304-264-0788 | |
Breanna Nicole Lilly, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 99 Tavern Rd, Martinsburg, WV 25401 Phone: 304-263-4999 Fax: 304-263-0984 |